Company / Shareholders' Equity
VYCOR MEDICAL INC Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$4.1M
FY2025
5-year range
-$4.1M / $2.4M
FY2021-FY2025
Trend
-10.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
VYCOR MEDICAL INC reports negative total equity of -$4M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$4M in FY2025.
Declined from -$3M to -$4M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- VYCOR MEDICAL INC's shareholders' equity has declined for 4 consecutive years.
- In FY2025, shareholders' equity decreased 10.8% year-over-year.
- Peak shareholders' equity was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -35.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.1M | -10.8% |
| FY2024 | -$3.7M | -11.0% |
| FY2023 | -$3.3M | -13.1% |
| FY2022 | -$2.9M | -222.8% |
| FY2021 | $2.4M | +220.9% |
| FY2020 | -$2.0M | -46.3% |
| FY2019 | -$1.4M | -76.2% |
| FY2018 | -$768.8K | -1044.0% |
| FY2017 | $81.4K | +408.0% |
| FY2016 | -$26.4K | -100.9% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026